What You Should Know:
– As a wholly-owned subsidiary of GHX, Syft joins GHX’s value-based care division’s growing portfolio of solutions that help modernize the supply chain.
Modernizing Healthcare Supply Chain to Overcome COVID-19 Related Challenges
As health systems shift to value-based care as well as overcome COVID-19-related challenges, it’s vital to modernize the supply chain with the technology, processes and people needed for data-driven decision-making, end-to-end visibility, automation and collaboration. – Syft helps health systems remove complexity and optimize the supply chain from dock-to-doc – from warehousing and distribution to the clinical point of use. Combining Syft’s approach to automation-driven supply chain management with GHX’s extensive network and collection of data will help healthcare leaders transform the supply chain to better meet the demands of a value-based future.
Syft represents the third acquisition GHX has made in the last two years that is focused on advancing healthcare’s movement to value-based care. In October 2021, GHX added Explorer Surgical, operator of a comprehensive digital and remote case support platform, and Lumere, provider of evidence-based data and analytics, in January 2020. Financial terms of the acquisition were not disclosed. Cleary Gottlieb Steen & Hamilton LLP acted as legal advisor to GHX. McDermott Will & Emery acted as legal advisor to Syft.
“To combat these challenges and accelerate the shift to value-based care, health systems need to transform the supply chain from a cost center to a value-driver,” said Bruce Johnson, president and CEO, GHX. “Forward-thinking leaders are investing in the digital transformation of the supply chain with the technology, data and processes required for greater collaboration, automation, visibility and data-driven decision-making. Syft provides the data and insight health systems need to reduce costs, improve efficiency and support care transformation.”